Substituted Heterocyclic GPR35 Modulators for Solid Tumor Immunotherapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective small molecule therapeutics to treat solid tumors.
Innovation Solution
Development of substituted benzofuran, benzothiophene, and indole carboxamide compounds and their pharmaceutical compositions that modulate G protein-coupled receptor 35 (GPR35) to promote anti-tumor immunity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional small molecule therapeutics are used, then treatment of solid tumors is attempted, but effectiveness is insufficient
Solution Approach 1:
The patent modifies molecular parameters by developing specific substituted benzofuran, benzothiophene, and indole carboxamide compounds with optimized chemical structures that enhance GPR35 modulation activity, thereby improving therapeutic effectiveness for solid tumors
Solution Approach 2:
The invention creates composite chemical structures combining different heterocyclic frameworks (benzofuran, benzothiophene, indole) with carboxamide groups to produce compounds with enhanced biological activity and selectivity for GPR35 receptor modulation
2Reliability
If GPR35 modulation is achieved, then anti-tumor immunity is enhanced, but compound complexity increases
Solution Approach 1:
The patent segments the molecular design into distinct functional modules: core heterocyclic frameworks (benzofuran, benzothiophene, indole), carboxamide linkers, and variable substituent groups (R1-R6), allowing systematic optimization of GPR35 binding while managing molecular complexity
Solution Approach 2:
The invention applies local quality by introducing specific substituents at defined positions on the core structures to enhance target selectivity and biological activity without requiring complete molecular redesign, thus managing complexity while improving effectiveness
Data Source
AI summary
Substituted benzofuran, benzothiophene, and indole carboxamide compounds, conjugates, and pharmaceutical compositions for use as immunotherapeutics in the treatment of cancer, such as solid tumors, are disclosed herein. The disclosed compounds are useful, among other things, in the treatment of a solid tumor originating in the breast, brain, kidney, ovary, cervix, pancreas, thyroid, colon, bladder, prostate, liver, stomach, or lung.